HomeNVTAQ • OTCMKTS
add
Invitae Corp
Nakaraang pagsara
$0.0020
Sakop ng araw
$0.00070 - $0.0011
Market cap
28.36K USD
Average na Volume
266.91K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2023info | Y/Y na pagbabago |
|---|---|---|
Kita | 121.24M | -9.21% |
Gastos sa pagpapatakbo | 141.95M | -21.71% |
Net na kita | -942.11M | -212.83% |
Net profit margin | -777.05 | -244.56% |
Kita sa bawat share | -0.10 | 76.19% |
EBITDA | -71.16M | 42.73% |
Aktuwal na % ng binabayarang buwis | 0.65% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2023info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 254.57M | -56.55% |
Kabuuang asset | 535.12M | -73.59% |
Kabuuang sagutin | 1.62B | -13.33% |
Kabuuang equity | -1.08B | — |
Natitirang share | 286.49M | — |
Presyo para makapag-book | -0.00 | — |
Return on assets | -25.00% | — |
Return on capital | -28.48% | — |
Cash Flow
Net change in cash
| (USD) | Set 2023info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -942.11M | -212.83% |
Cash mula sa mga operasyon | -66.90M | 48.02% |
Cash mula sa pag-invest | 5.12M | -88.32% |
Cash mula sa financing | -3.38M | -99.94% |
Net change in cash | -65.16M | 24.76% |
Malayang cash flow | -29.46M | -38.14% |
Tungkol
Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012.
In 2017, Invitae acquired Good Start Genetics and CombiMatrix. In 2020, Invitae announced the acquisition of ArcherDX for $1.4 billion. In 2021, Invitae announced the acquisition of health care AI startup Ciitizen for $325 million.
In early 2024, Invitae filed for Chapter 11 bankruptcy protection, and later announced an agreement for an acquisition by Labcorp. Wikipedia
Itinatag
2010
Headquarters
Website
Mga Empleyado
1,700
